Although there is no clear explanation for the different patterns of IL-33 expression in non-IPF and IPF fibroblasts in our study and that of Luzina and colleagues, it may reflect differences in culture conditions and their inclusion of data from scleroderma patients [14]. This evidence concerns the gene IL33 and scleroderma.